Difference between revisions of "Forodesine (Fodosine)"
Jump to navigation
Jump to search
(Created page with "==Mechanism of action== Purine nucleoside phosphorylase (PNP) inhibitor ==Preliminary data== # Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, ...") |
m |
||
| Line 3: | Line 3: | ||
==Preliminary data== | ==Preliminary data== | ||
| + | |||
| + | ===[[T-cell lymphoma]]=== | ||
# Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. [http://annonc.oxfordjournals.org/content/25/9/1807.full.html link to original article] [http://www.ncbi.nlm.nih.gov/pubmed/24948692 PubMed] | # Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. [http://annonc.oxfordjournals.org/content/25/9/1807.full.html link to original article] [http://www.ncbi.nlm.nih.gov/pubmed/24948692 PubMed] | ||
| − | [[Category: | + | ==Also known as== |
| + | Immucillin H | ||
| + | |||
| + | [[Category:Drug index]] | ||
| + | [[Category:Chemotherapy]] | ||
[[Category:T-cell lymphoma medications]] | [[Category:T-cell lymphoma medications]] | ||
| + | |||
| + | [[Category:Investigational]] | ||
Revision as of 19:40, 12 November 2014
Mechanism of action
Purine nucleoside phosphorylase (PNP) inhibitor
Preliminary data
T-cell lymphoma
- Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. link to original article PubMed
Also known as
Immucillin H